Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Downgrades
Updated: Tuesday, June 9, 2026 8:43:23 AM
Date
Broker
Company
Symbol
To
From
Target
2/20/24
Wedbush
HEALTHCARE REALTY TRUST
HR
Neutral
Outperform
$15 Down From $19
2/14/24
William Blair
Blackline Inc.
BL
Market Perform
Outperform
N/A
2/14/24
William Blair
QuidelOrtho Corporation
QDEL
Market Perform
Outperform
N/A
2/8/24
Wedbush
GoPro Inc.
GPRO
Neutral
Outperform
$2 Down From $4
1/22/24
William Blair
The Vita Coco Company, Inc.
COCO
Market Perform
Outperform
N/A
11/20/23
Wedbush
KB Home
KBH
Neutral
Outperform
$55
11/14/23
Wedbush
New York Community Bancorp Inc.
NYB
Underperform
Neutral
$8 Down From $12
11/14/23
William Blair
The Beauty Health Company
SKIN
Market Perform
Outperform
N/A
11/8/23
Wedbush
Zentalis Pharmaceuticals, LLC
ZNTL
Neutral
Outperform
$12 Down From $38
11/6/23
William Blair
EnerSys
ENS
Market Perform
Outperform
N/A
11/6/23
William Blair
EngageSmart, Inc.
ESMT
Market Perform
Outperform
N/A
11/3/23
Wedbush
First Foundation
FFWM
Neutral
Outperform
$6 Down From $7
11/3/23
Wedbush
New York Community Bancorp Inc.
NYB
Neutral
Outperform
$11 Down From $12
11/3/23
Wedbush
Comerica Inc.
CMA
Neutral
Outperform
$45 Down From $47
11/3/23
William Blair
Fortinet, Inc.
FTNT
Market Perform
Outperform
N/A
11/3/23
William Blair
BILL Holdings, Inc.
BILL
Market Perform
Outperform
N/A
10/24/23
William Blair
Sealed Air Corp.
SEE
Market Perform
Outperform
N/A
10/24/23
William Blair
Markforged Holding Corp
MKFG
Market Perform
Outperform
N/A
10/20/23
Wedbush
Regions Financial Corp.
RF
Neutral
Outperform
$15 Down From $20
10/18/23
Wedbush
Freeline Therapeutics Holdings plc
FRLN
Neutral
Outperform
$5 Down From $8
9/20/23
William Blair
ARS Pharmaceuticals, Inc.
SPRY
Market Perform
Outperform
N/A
9/19/23
Wedbush
Kinnate Biopharma Inc.
KNTE
Neutral
Outperform
$2 Down From $14
9/18/23
William Blair
NetApp Inc.
NTAP
Market Perform
Outperform
N/A
9/18/23
William Blair
Dropbox, Inc
DBX
Market Perform
Outperform
N/A
9/12/23
William Blair
Sight Sciences, Inc.
SGHT
Market Perform
Outperform
N/A
8/18/23
Wedbush
Beazer Homes USA Inc.
BZH
Neutral
Outperform
$32
8/14/23
Wedbush
Atreca Inc.
BCEL
Neutral
Outperform
$1 Down From $4
6/26/23
Wedbush
Unity Biotechnology, Inc.
UBX
Neutral
Outperform
$2 Down From $3
5/15/23
Wedbush
SoFi Technologies, Inc.
SOFI
Underperform
Neutral
$2.50 Down From $5
5/4/23
Wedbush
Diebold Nixdorf Inc.
DBD
Neutral
Outperform
$1 Down From $5
5/2/23
Wedbush
SoFi Technologies, Inc.
SOFI
Neutral
Outperform
$5 Down From $8
11/8/22
Wedbush
Williams-Sonoma Inc.
WSM
Neutral
Outperform
$110 Down From $190
11/1/22
Wedbush
Steven Madden Ltd
SHOO
Neutral
Outperform
$29 Down From $43
11/1/22
Wedbush
Varonis Systems Inc.
VRNS
Neutral
Outperform
$20 Down From $40
10/31/22
Wedbush
Y-mAbs Therapeutics, Inc.
YMAB
Neutral
Outperform
$6 Down From $21
10/18/22
Wedbush
CARVANA CO.
CVNA
Neutral
Outperform
$15 Down From $50
10/4/22
Wedbush
Poshmark, Inc.
POSH
Neutral
Outperform
$17.50 Up From 14
9/9/22
William Blair
Zumiez Inc.
ZUMZ
Market Perform
Outperform
N/A
9/1/22
Wedbush
Liquidia Corporation
LQDA
Underperform
Neutral
$3 Down From $4
7/26/22
Wedbush
Chewy, Inc.
CHWY
Neutral
Outperform
$44 Up From $35
Buy this Content
Editors Pick
Nuvalent Stock Climbs 39% On $10.6 Bln Takeover Deal With GSK
June 09, 2026 08:05 ET
OpenAI Joins IPO Race With Confidential S-1 Filing
June 09, 2026 05:10 ET
Tate & Lyle Stock Up On $3.6 Bln Cash Deal To Be Bought By Ingredion
June 08, 2026 07:11 ET
SpaceX Aims To Raise Around $75 Bln In IPO, Musk May Become World's First Trillionaire
June 04, 2026 07:12 ET